Stockscreener 앱 받기
26.27
2.98%
0.76
시장 영업 전:
26.57
0.30
+1.14%
전일 마감가:
$25.51
열려 있는:
$25.66
하루 거래량:
1.16M
Relative Volume:
0.73
시가총액:
$4.19B
수익:
$295.41M
순이익/손실:
$-49.64M
주가수익비율:
-80.24
EPS:
-0.3274
순현금흐름:
$-29.54M
1주 성능:
+7.58%
1개월 성능:
-10.74%
6개월 성능:
+84.87%
1년 성능:
+53.45%
1일 변동 폭
$0.00
$0.00
1주일 범위
$23.82
$26.45
52주 변동 폭
$12.00
$30.74
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
명칭
Adaptive Biotechnologies Corp
전화
206-659-0067
주소
1165 EASTLAKE AVE E, SEATTLE, WA
Compare ADPT vs TMO, DHR, NTRA, A, IQV
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
26.27 | 4.19B | 295.41M | -49.64M | -29.54M | -0.3274 |
TMO
Thermo Fisher Scientific Inc
|
684.89 | 253.24B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
232.97 | 163.77B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
404.90 | 58.36B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
175.96 | 49.61B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
273.60 | 45.03B | 16.63B | 1.39B | 2.12B | 8.0674 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 재개 | Morgan Stanley | Equal-Weight |
| 2025-09-30 | 개시 | Guggenheim | Buy |
| 2025-06-18 | 개시 | Craig Hallum | Buy |
| 2025-03-21 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-12-21 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | 개시 | Credit Suisse | Underperform |
| 2022-06-03 | 개시 | Piper Sandler | Neutral |
| 2022-02-16 | 재확인 | BTIG Research | Buy |
| 2022-02-16 | 재확인 | BofA Securities | Buy |
| 2022-02-16 | 재확인 | Goldman | Neutral |
| 2022-02-16 | 재확인 | JP Morgan | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-03-03 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-10-08 | 재개 | BTIG Research | Buy |
| 2020-09-09 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-06-03 | 개시 | Goldman | Buy |
| 2019-07-23 | 개시 | BTIG Research | Buy |
| 2019-07-22 | 개시 | BofA/Merrill | Buy |
| 2019-07-22 | 개시 | Cowen | Outperform |
| 2019-07-22 | 개시 | Goldman | Neutral |
| 2019-07-22 | 개시 | Guggenheim | Buy |
| 2019-07-22 | 개시 | William Blair | Outperform |
모두보기
Adaptive Biotechnologies Corp 주식(ADPT)의 최신 뉴스
Form 4 Adaptive Biotechnologies Corp: Julie Rubinstein (President and COO) For: 14 October - Investing.com Nigeria
Form 4 Adaptive Biotechnologies Corp: Julie Rubinstein (President and COO) For: 14 October - Investing.com UK
COO sold 35,643 shares and exercised options at $12.14 at Adaptive Biotechnologies (ADPT). - Stock Titan
Form 4 Adaptive Biotechnologies Corp: Julie Rubinstein (President and COO) For: 9 October - Investing.com Nigeria
The COO exercised options and sold 35,643 Adaptive Biotechnologies (ADPT) shares. - Stock Titan
At $12.14 per share, Adaptive Biotechnologies (ADPT) COO exercised options on each of three share-sale dates. - Stock Titan
An officer sells 6,444 shares at $30 each under a trading plan at Adaptive Biotechnologies (ADPT). - Stock Titan
Adaptive Biotechnologies Officer Susan Bobulsky Files to Sell 6,444 Shares Under 10b5-1 Plan - Kalkine Media
Officer Susan Bobulsky proposes selling 6,444 Adaptive Biotechnologies (ADPT) shares. - Stock Titan
Adaptive Biotechnologies COO Julie Rubinstein sells $1m in stock - Investing.com
Form 4 Adaptive Biotechnologies Corp For: 5 October By Investing.com - Investing.com Nigeria
Form 4 Adaptive Biotechnologies Corp For: 5 October By Investing.com - Investing.com UK
An officer exercises options and sells Adaptive Biotechnologies (ADPT) shares under a preset plan. - Stock Titan
A COO exercises $12.14 options and sells 35,643 Adaptive Biotechnologies (ADPT) shares. - Stock Titan
Adaptive Biotechnologies Officer Julie Rubinstein Files Form 144 to Sell 379,777 Shares - Kalkine Media
Options exercised over three months will supply an officer's planned sale at Adaptive Biotechnologies (ADPT). - Stock Titan
Form 4 Adaptive Biotechnologies Corp For: 28 September By Investing.com - Investing.com Canada
Form 4 Adaptive Biotechnologies Corp For: 28 September By Investing.com - Investing.com South Africa
Adaptive Biotechnologies (ADPT) HR chief sells over 100,000 shares under preset plan - Stock Titan
Adaptive biotechnologies chief commercial officer sells $32,265 in shares. - Investing.com
Adaptive Biotechnologies (NASDAQ: ADPT) CCO sells shares under pre-set trading plan - Stock Titan
Adaptive Biotechnologies (ADPT) officer to sell 142K shares - Stock Titan
Officer at Adaptive Biotechnologies (NASDAQ: ADPT) plans sale of 1,195 shares - Stock Titan
Adaptive Biotechnologies (NASDAQ: ADPT) director reports stock gift, still holds 66,100 shares - Stock Titan
Adaptive Biotechnologies Corp (ADPT) Key Financial Ratios – Valuation, Profitability & More - Value Research
Morgan Stanley’s healthcare conference sets a biotech chat for Sept. 15 - Stock Titan
Adaptive Biotechnologies Corp (ADPT) Peer Comparison – Compare with Others - Value Research
Director Katey Owen Sells 9,615 Shares of Adaptive Biotechnologies Corp (ADPT) - GuruFocus
Adaptive Biotechnologies director Owen sells $249,990 in stock. By Investing.com - Investing.com India
Adaptive Biotechnologies director Owen sells $249,990 in stock. By Investing.com - Investing.com Canada
Adaptive Biotechnologies director Owen sells $249,990 in stock. - Investing.com
Adaptive Biotechnologies Corp (ADPT) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
Adaptive Biotechnologies (NASDAQ: ADPT) director sells at $26, keeps 78,639 - Stock Titan
Adaptive Biotechnologies stock hits 52-week high at $26.63 By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies stock hits 52-week high at $26.63 - Investing.com
Adaptive Biotechnologies stock hits 52-week high at $26.63 - Investing.com India
Adaptive Biotechnologies stock hits 52-week high at $26.63 By Investing.com - Investing.com UK
Adaptive Biotech (NASDAQ: ADPT) director lines up $249,990 stock sale - Stock Titan
Adaptive Biotechnologies Stock Has Doubled in the Past Year. Here’s What Could Come Next. - inkl
Bank of America Corp DE Acquires 421,645 Shares of Adaptive Biotechnologies Corporation $ADPT - MarketBeat
Adaptive Biotechnologies Stock Has Doubled in the Past Year. Here’s What Could Come Next. - Yahoo Finance
Adaptive Biotechnologies director Robert Hershberg sells $748k in shares - Investing.com
Adaptive Biotechnologies director Robert Hershberg sells $748k in shares By Investing.com - Investing.com South Africa
Adaptive Biotechnologies director Robert Hershberg sells $748k in shares By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies director Robert Hershberg sells $748k in shares By Investing.com - Investing.com India
Adaptive Biotechnologies director Robert Hershberg sells $748k in shares By Investing.com - Investing.com UK
Adaptive Biotechnologies (NASDAQ:ADPT) Director Robert Hershberg Sells 30,664 Shares of Stock - MarketBeat
Adaptive Biotechnologies director Robert Hershberg sells $748k in shares - Investing.com
Adaptive Biotechnologies Director Robert Hershberg Executes Stock Option and Sells Shares - Kalkine Media
Adaptive Biotech (NASDAQ: ADPT) ex-officer to sell 402,160 shares - Stock Titan
Adaptive Biotechnologies Corp (ADPT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Adaptive Biotechnologies Corp 주식 (ADPT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| RUBINSTEIN JULIE | President and COO |
Oct 21 '26 |
Option Exercise |
12.14 |
11,881 |
144,235 |
389,683 |
| RUBINSTEIN JULIE | President and COO |
Oct 21 '26 |
Sale |
25.41 |
11,881 |
301,877 |
377,802 |
| RUBINSTEIN JULIE | President and COO |
Oct 20 '26 |
Option Exercise |
12.14 |
11,881 |
144,235 |
389,683 |
| RUBINSTEIN JULIE | President and COO |
Oct 20 '26 |
Sale |
24.53 |
11,881 |
291,473 |
377,802 |
| RUBINSTEIN JULIE | President and COO |
Oct 19 '26 |
Sale |
24.05 |
11,881 |
285,738 |
377,802 |
| RUBINSTEIN JULIE | President and COO |
Oct 16 '26 |
Sale |
24.24 |
11,881 |
288,011 |
377,802 |
| RUBINSTEIN JULIE | President and COO |
Oct 16 '26 |
Option Exercise |
12.14 |
11,881 |
144,235 |
389,683 |
| RUBINSTEIN JULIE | President and COO |
Oct 15 '26 |
Option Exercise |
12.14 |
11,881 |
144,235 |
389,683 |
| RUBINSTEIN JULIE | President and COO |
Oct 15 '26 |
Sale |
25.61 |
11,881 |
304,272 |
377,802 |
| RUBINSTEIN JULIE | President and COO |
Oct 14 '26 |
Option Exercise |
12.14 |
11,881 |
144,235 |
389,683 |
0.56%
0.16%
자본화:
|
볼륨(24시간):